Saturday 7 November 2026 Export RARE’s income statement to Excel — free account

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $673.0 million, up 20.2% from fiscal 2024.

Revenue: +8.13%
EPS: +36.2%
Free cash flow: +12.5%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

15.43 0.14 −0.90%

Follow RARE

Alert me

Market cap: $1.5B
P/E: 0.0×
Fwd P/E: −4.9×
Dividend yield: —
F-score: 5/9
Altman Z: −3.57
Beneish M: −2.68
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	3	3	3	5	+8 more TTM periods Free account
ROE Full definition →	285.68%	838.86%	1,327.47%	(657.14%)
ROA Full definition →	(44.08%)	(45.60%)	(46.70%)	(37.89%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(135.75%)	(119.59%)	(106.65%)	(70.90%)
Average Days of Receivables Full definition →	83.00	101.81	65.92	85.69
Free Cash Flow per Share Full definition →	(4.38)	(4.85)	(5.05)	(4.94)
Free Cash Flow Full definition →	(447.00)	(494.00)	(508.00)	(487.00)
Capital Expenditures Full definition →	(10.00)	(9.00)	(11.00)	(21.00)
Other line items
Cash ROIC Full definition →	406.36%	(49,400.00%)	(287.01%)	(81.17%)
Accounts Receivable Turnover Full definition →	5.24	4.42	6.10	4.81
Accounts Payable Turnover Full definition →	2.92	3.30	2.46	3.11
Inventory Turnover Full definition →	2.25	2.29	2.18	2.25
Average Days of Payables Full definition →	131.40	117.64	139.36	103.81
Days of Inventory on Hand Full definition →	172.28	177.98	182.50	174.13
Tax Rate Full definition →	(0.01)	0.01	0.01	0.01
Research and Development Expense of Revenue Full definition →	97.40%	107.81%	115.07%	111.44%
Selling, General and Administrative Expense of Revenue Full definition →	49.45%	48.95%	52.24%	51.86%
Share Based Compensation of Revenue Full definition →	18.49%	19.39%	21.34%	22.73%
Interest Coverage Full definition →	(5.63)	(6.86)	(8.13)	(8.63)
Operating CF/Net income Full definition →	0.83	0.83	0.82	0.81
Depreciation/Fixed assets Full definition →	0.14	0.13	0.13	0.13
Capex/Depreciation Full definition →	(0.30)	(0.29)	(0.35)	(0.68)
Revenue per Share Full definition →	7.15	7.04	6.66	6.83
Operating CF per Share Full definition →	(4.28)	(4.76)	(4.94)	(4.73)
Capex per Share Full definition →	(0.10)	(0.09)	(0.11)	(0.21)
Capex to Sales Full definition →	0.01	0.01	0.02	0.03

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly